DDX53 and neoplasm: However, in contrast to the CT26/p95HER2 tumor growth of subcutaneous models, the survival of intravenously inoculated CT26/p95HER2 bearing mice indicated that BVAC-K1117 is superior to BVAC with other antigens (Figure 4C).